University of Calgary: Multiple Sclerosis trials
The registry lists 11 Multiple Sclerosis studies with University of Calgary as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 7Phase 3 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Transcranial Magnetic Stimulation for Depression in Multiple SclerosisNot yet recruitingNCT07562074Phase 1
- Cannabis (THC vs. CBD) in Multiple SclerosisRecruitingNCT06261489Phase 2
- Remote Ischemic Conditioning in PPMSNot yet recruitingNCT06171334Not applicable
- Implementation of an App-based Walking Aid Skills Training ProgramRecruitingNCT05347875Not applicable
- Hydroxychloroquine and Indapamide in SPMSStatus unknownNCT05013463Phase 2
- Minocycline in MS: Confirmation of BenefitTerminatedNCT04291456Phase 3
- Hydroxychloroquine in Primary Progressive Multiple SclerosisCompletedNCT02913157Phase 2
- Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)CompletedNCT02493049Phase 2
- Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)CompletedNCT02308137Phase 2
- Safety and Tolerability of Quetiapine in Multiple SclerosisCompletedNCT02087631Phase 1/2
- Neuroprotection and Repair in Optic NeuritisTerminatedNCT01073813Phase 2